Drug application
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE (CHLORPHENIRAMINE MALEATE, HYDROCODONE BITARTRATE, PSEUDOEPHEDRINE HYDROCHLORIDE)
Drugs@FDA ANDA 206660 · APOZEAL PHARMS
Key facts
| Drug name | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE |
|---|---|
| Active ingredients | CHLORPHENIRAMINE MALEATE, HYDROCODONE BITARTRATE, PSEUDOEPHEDRINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 206660 |
| Company | APOZEAL PHARMS |
| Dosage forms | SOLUTION, ORAL |
| Strength | 4MG/5ML;5MG/5ML;60MG/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | May 15, 2017 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.